Edesa Biotech (EDSA) Long-Term Deferred Tax (2020 - 2023)
Edesa Biotech (EDSA) posted Long-Term Deferred Tax of $585000.0 for Q3 2023, up 1525.0% sequentially from $36000.0 in Q3 2022, and up 1525.0% YoY from $36000.0 in Q3 2022.
Edesa Biotech (EDSA) Long-Term Deferred Tax (2020 - 2023) Analysis & Trends
Edesa Biotech has reported Long-Term Deferred Tax for 3 years, with the latest figure at $585000.0 in Q3 2023.
- Quarterly Long-Term Deferred Tax rose 1525.0% year-over-year to $585000.0 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $585000.0 (up 1525.0% YoY) and the FY2023 annual result came in at $585000.0, up 1525.0% from the prior year.
- Long-Term Deferred Tax climbed to $585000.0 in Q3 2023 per EDSA's latest filing, from $36000.0 in the prior quarter.
- Over five years, Long-Term Deferred Tax peaked at $585000.0 in Q3 2023 and troughed at $36000.0 in Q3 2022.
- A 3-year average of $364666.7 and a median of $473000.0 in 2020 frame the typical range for Long-Term Deferred Tax.
- The widest YoY moves for Long-Term Deferred Tax: up 1525.0% in 2023, down 1525.0% in 2023.
- Over 3 years, Long-Term Deferred Tax stood at $473000.0 in 2020, then plunged by 92.39% to $36000.0 in 2022, then soared by 1525.0% to $585000.0 in 2023.
- According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $585000.0, $36000.0, and $473000.0 for Q3 2023, Q3 2022, and Q3 2020 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Edesa Biotech | 40.44 Mn | 40.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 585,000.00 |
| Sep 30, 2022 | 36,000.00 |
| Sep 30, 2020 | 473,000.00 |